The development of a core outcomes set for self-management interventions for patients living with obesity.


Journal

Clinical obesity
ISSN: 1758-8111
Titre abrégé: Clin Obes
Pays: England
ID NLM: 101560587

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 05 07 2021
received: 03 02 2021
accepted: 08 09 2021
pubmed: 8 10 2021
medline: 8 1 2022
entrez: 7 10 2021
Statut: ppublish

Résumé

Self-management interventions (SMIs) can improve the life of patients living with obesity. However, there is variability in the outcomes used to assess the effectiveness of SMIs and these are often not relevant for patients. In the context of COMPAR-EU, our aim was to develop a core outcome set (COS) for the evaluation of SMIs for patients with obesity. We followed a four steps multimethod approach: (1) the development of the initial catalogue of outcomes; (2) a scoping review of reviews on patients' values and preferences on outcomes of self-management (SM); (3) a Delphi survey including patients and patient representatives to rate the importance of outcomes; and (4) a 2-day consensus workshop with patients, patient representatives, healthcare professionals and researchers. The initial catalogue included 82 outcomes. Ten patients and patient's representatives participated in the Delphi survey. We identified 16 themes through the thematic synthesis of the scoping review that informed 37.80% of the outcomes on initial catalogue. Five patients, five healthcare professionals, and four researchers participated in the consensus workshop. After the consensus process, 15 outcomes were selected to be part of the final COS, and five supplementary outcomes were also provided. We developed a COS for the evaluation of SMIs in obesity with a significant involvement of patients and other key stakeholders. This COS will help improving data synthesis and increasing the value of SM research data in healthcare decision making.

Identifiants

pubmed: 34617681
doi: 10.1111/cob.12489
pmc: PMC9285702
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12489

Subventions

Organisme : EU Horizon 2020
ID : 754936

Informations de copyright

© 2021 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

Références

Obes Rev. 2020 Feb;21(2):e12961
pubmed: 31756274
Clin Obes. 2011 Apr;1(2-3):99-109
pubmed: 25585575
Obes Res. 1998 Jul;6(4):311-5
pubmed: 9688109
PLoS Med. 2016 Oct 18;13(10):e1002148
pubmed: 27755541
Trials. 2014 Dec 26;15:511
pubmed: 25540987
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
PLoS One. 2019 Dec 12;14(12):e0225980
pubmed: 31830081
Clin Med (Lond). 2002 May-Jun;2(3):227-9
pubmed: 12108472
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
BMJ Open. 2020 Jan 19;10(1):e034680
pubmed: 31959612
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S1-8
pubmed: 22386504
Health Psychol Rev. 2017 Jun;11(2):145-163
pubmed: 28281891
Trials. 2012 Aug 06;13:132
pubmed: 22867278
PLoS Med. 2011 Jan 25;8(1):e1000393
pubmed: 21283604
Health Qual Life Outcomes. 2017 Aug 30;15(1):126
pubmed: 28851437
Int J Obes (Lond). 2008 Jun;32(6):881-91
pubmed: 18414420
J Am Acad Nurse Pract. 2011 Nov;23(11):592-601
pubmed: 22023231
J Clin Epidemiol. 2019 Dec;116:150-154
pubmed: 31129260
Br J Gen Pract. 2015 Apr;65(633):e240-7
pubmed: 25824184
Res Involv Engagem. 2016 Jul 08;2:25
pubmed: 29507761
J Nurs Scholarsh. 2012 Jun;44(2):136-44
pubmed: 22551013
Ann Behav Med. 2003 Aug;26(1):1-7
pubmed: 12867348
Clin Obes. 2011 Apr;1(2-3):110-26
pubmed: 25585576
Health Technol Assess. 2011 Dec;15(43):1-164
pubmed: 22176717
Pharmacoeconomics. 2012 Dec 1;30(12):1133-43
pubmed: 23072660
Int J Qual Stud Health Well-being. 2011;6(4):
pubmed: 22121389
PLoS Med. 2016 Nov 29;13(11):e1002187
pubmed: 27898680
J Midwifery Womens Health. 2014 Jul-Aug;59(4):380-7
pubmed: 24256087
J Adv Nurs. 1994 Jun;19(6):1221-5
pubmed: 7930104
J Rehabil Med. 2004 Jul;(44 Suppl):12-21
pubmed: 15370743
Health Educ Res. 2008 Apr;23(2):347-58
pubmed: 17884836
BMJ Open. 2015 Oct 12;5(10):e008372
pubmed: 26459486
J Telemed Telecare. 2018 May;24(4):290-302
pubmed: 28181859
BMJ Paediatr Open. 2017 Jul 26;1(1):e000048
pubmed: 29637104
BMC Med Res Methodol. 2005 Dec 01;5:37
pubmed: 16321161
Patient Educ Couns. 2017 May;100(5):897-908
pubmed: 28089308
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Obes Rev. 2014 Nov;15(11):920-32
pubmed: 25112559
Obes Rev. 2013 Sep;14(9):707-20
pubmed: 23639053
Obes Rev. 2015 Jan;16(1):88-106
pubmed: 25442513
Health Expect. 2013 Jun;16(2):119-42
pubmed: 21645186
Fam Pract. 2014 Aug;31(4):389-98
pubmed: 24891472
Obesity (Silver Spring). 2015 Sep;23(9):1743-60
pubmed: 26260279
Trials. 2017 Oct 23;18(1):490
pubmed: 29061190
Clin Obes. 2022 Feb;12(1):e12489
pubmed: 34617681

Auteurs

Claudia Valli (C)

Iberoamerican Cochrane Centre Barcelona-Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Universidad Autónoma de Barcelona, Barcelona, Spain.

Rosa Suñol (R)

Universitat Autònoma de Barcelona, Barcelona, Spain.
Avedis Donabedian Research Institute (FAD), Spain.
Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC), Barcelona, Spain.

Carola Orrego (C)

Universitat Autònoma de Barcelona, Barcelona, Spain.
Avedis Donabedian Research Institute (FAD), Spain.
Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC), Barcelona, Spain.

Ena Niño de Guzmán (E)

Iberoamerican Cochrane Centre Barcelona-Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Universidad Autónoma de Barcelona, Barcelona, Spain.
Cancer Prevention and Control Programme, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Valentina Strammiello (V)

European Patients' Forum (EPF), Brussels, Belgium.

Nina Adrion (N)

OptiMedis AG, Hamburg, Germany.

Kaisa Immonen (K)

European Patients' Forum (EPF), Brussels, Belgium.

Lyudmil Ninov (L)

European Patients' Forum (EPF), Brussels, Belgium.

Marieke van der Gaag (M)

Netherlands Institute for Health Services Research (Nivel), The Netherlands.

Marta Ballester (M)

Universitat Autònoma de Barcelona, Barcelona, Spain.
Avedis Donabedian Research Institute (FAD), Spain.
Cancer Prevention and Control Programme, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Pablo Alonso-Coello (P)

Iberoamerican Cochrane Centre Barcelona-Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH